The human genome encodes at least 42 different members of the transforming growth factor-β superfamily of growth factors. Bone morphogenetic proteins (BMPs) are the largest subfamily of proteins within the transforming growth factor-β superfamily and are involved in numerous cellular functions including development, morphogenesis, cell proliferation, apoptosis, and extracellular matrix synthesis. This article first reviews BMPs and BMP receptors, BMP signaling pathways, and mechanisms controlling BMP signaling. Second, we review BMP and BMP receptor expression during embryonic ocular development/ differentiation and in adult ocular tissues. Lastly, future research directions with respect to BMP, BMP receptors, and ocular tissues are suggested.
Get full access to this article
View all access options for this article.
References
1.
Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-beta superfamily signaling. Genes Cells7: 1191–1204, 2002.
2.
Reddi AH. BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev16:249–250, 2005.
3.
Yanagita M. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev16: 309–317, 2005.
4.
Kawabata M, Imamura T, Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev9:49–61, 1998.
5.
Uzel M, Scott I, Babakhanlou-Chase H, Palamakumbura A, Pappano W, Hong H, Greenspan D, Trackman P. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process prolysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J Biol Chem276: 22537–22543, 2001.
6.
Massague J. The transforming growth factor-beta family. Ann Rev Cell Biol6:597–641, 1990.
7.
Cho K, Blitz I. BMPs, Smads and metalloproteases: extracellular and intracellular modes of negative regulation. Curr Opin Genet Dev8: 443–449, 1998.
8.
Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev16:251–263, 2005.
9.
Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R, Massague J. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell48:409–415, 1987.
10.
Cheifetz S, Hernadez H, Laiho M, Iwata KK, Massague J. Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem265: 20533–20538, 1990.
11.
Miyazono K. TGF-β signaling by Smad proteins. Cytokine Growth Factor Rev11:15–22, 2000.
12.
Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell11:1023–1035, 2000.
13.
Rosenzweig B, Imamura T, Okadome T, Cox G, Yamashita H, Ten Dijke P. Cloning and characterization of a human type II receptor for bone morphogenetic protein. Proc Natl Acad Sci U S A92:7632–7636, 1995.
14.
Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem277:5330–5338, 2002.
Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet29:117–129, 2001.
17.
Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene23:2838–2849, 2004.
18.
Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci114:1483–1489, 2001.
19.
Knockaert M, Sapkota G, Alarcon C, Massague J, Brivaniou A. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A103:11940–11945, 2006.
20.
Olson JM, Hallahan AR. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med10:125–129, 2004.
21.
Iwasaki S, Iguchi M, Hoshino R, Tsujimoto M, Kohno M. Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC 12 cells by bone morphogenetic protein-2. J Biol Chem274:26503–26510, 1999.
22.
Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T. BMP-2 induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem275: 17647–17652, 2000.
23.
Tazoe M, Mogi M, Goto S, Togari A. Involvement of p38 MAP kinase in bone morphogenetic protein-4 induced osteoprotegerin in mouse bone-marrow-derived stromal cells. Arch Oral Biol48:615–619, 2003.
24.
Hofmann M, Zaper J, Bernd A, Bereiter-Hahn J, Kaufmann R, Kippenberger S. Mechanical pressure-induced phosphorylation of p38 mitogen-activated protein kinase in epithelial cells via Src and protein kinase C. Biochem Biophys Res Commun316:673–679, 2004.
25.
Von Bubnoff A, Cho KW. Intracellular regulation in vertebrates: pathway or network? Dev Biol239:1–14, 2001.
26.
Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol250:231–250, 2002.
27.
Shimasaki S, Moore RK, Otsuka F, Erickson GF. The bone morphogenetic protein system in mammalian reproduction. Endocr Rev25:72–101, 2004.
28.
Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C. Silencing of TGF-beta signaling by the pseudoreceptor BAMBI. Nature401:480–485, 1999.
29.
von Bubnoff A, Cho K. Intracellular BMP signaling regulation in vertebrates: pathway or network? Dev Biol239:1–14, 2001.
30.
Zhu H-J, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. A Smad ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature400:687–693, 1999.
31.
Pera EM, Ikeda A, Eivers E, De Robertis EM. Integration of IGF, FGF and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev17:3023–3028, 2003.
32.
Peterson R, Andhare R, Rousche K, Knudson W, Wang W, Grossfield J, Thomas R, Hollingsworth R, Knudson C. CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J Cell Biol166:1081–1091, 2004.
33.
Samad T, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong S-J, Campagana J, Perusini S, Fabrizio D, Schneyer A, Lin AY, Brivanlou A, Attisano L, Woolf C. DRAGON, a bone morphogenetic protein co-receptor. J Biol Chem280:14122–14129, 2005.
34.
Sapkota G, Alarcon C, Spagnoli F, Brivaniou A, Massague J.Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell25:441–454, 2007.
35.
Babitt J, Zhang Y, Samad T, Xia Y, Tang J, Campagana J, Schneyer A, Woolf C, Lin H. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem280:29820–29827, 2005.
36.
Korchynskyi O, Dechering K, Sijbers A, Olijve W, ten Dijke P. Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation. J Bone Miner Res18:1177–1185, 2003.
37.
Clancy B, Johnson J, Lambert A, Rezvankhah S, Wong A, Resmini C. A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. Bone33:46–63, 2003.
38.
Peng Y, Kang Q, Cheng H, Li X, Sun M, Jiang W. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem90:1149–1165, 2003.
39.
Ying Q, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell115:281–292, 2003.
40.
Abe J. Bone morphogenetic protein (BMP) family, Smad signaling and Id helix-loop-helix proteins in the vasculature: the continuous mystery of BMPs pleotropic effects. J Mol Cell Cardiol41:4–7, 2006.
41.
Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer5:603–614, 2005.
42.
Norton J. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci113:3897–3905, 2000.
43.
Zwijsen A, Verschueren K, Huylebroeck D. New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett546:133–139, 2003.
44.
Hruska K, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res97:105–114, 2005.
45.
Urist MR. Bone: formation by autoinduction. Science150:893–899, 1965.
46.
Shimasaki S, Zachow R, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang R. A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci U S A96:7282–7287, 1999.
47.
Soderstrom S, Ebendal T. Localized expression of BMP and GDF mRNA in the rodent brain. J Neurosci Res56:482–492, 1999.
48.
Chen M, Carpenter D, Zhao G. Expression of bone morphogenetic protein 7 in murine epididymis is developmentally regulated. Biol Reprod60:1503–1508, 1999.
49.
Kleeff J, Maruyama H, Ishiwata T, Sawhney H, Friess H, Buchler M, Korc M. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vitro. Gastroenterology116:1202–1216, 1999.
50.
Arnold S, Tims E, McGrath B. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine11:1031–1037, 1999.
51.
Jena N, Martin-Seisdedos C, McCue P, Croce CM. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res230:28–37, 1997.
52.
Hogan B. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev10:1580–1594, 1996.
53.
Detmer K, Walker AN. Bone morphogenetic proteins act synergistically with haematopoietic cytokines in the differentiation of haemato-poietic progenitors. Cytokine17:36–42, 2001.
54.
Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, Ginsberg MD.The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats. Brain Res905:81–90, 2001.
55.
Paralkar VM, Weeks BS, Yu YM, Kleinman HK, Reddi A. Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. J Cell Biol119:1721–1728, 1992.
56.
Reddi A. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev8:11–20, 1997.
57.
Furuta Y, Hogan BL. BMP4 is essential for lens induction in the mouse embryo. Genes Dev12:3764–3775, 1998.
58.
Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev9:2808–2820, 1995.
59.
Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev9:2795–2807, 1995.
60.
Wawersik S, Purcell P, Rauchman M, Dudley AT, Robertson EJ, Maas R. BMP7 acts in murine lens placode development. Dev Biol207:176–188, 1999.
61.
Dudley A, Robertson E. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn208:349–362, 1997.
62.
Lang RA. Pathways regulating lens induction in the mouse. Int J Dev Biol48:783–791, 2004.
63.
Solursh M, Langille RM, Wood J, Sampath TK. Osteogenic protein-1 is required for mammalian eye development. Biochem Biophys Res Commun218:438–443, 1996.
64.
de Iongh RU, Gordon-Thomson C, Chamberlain CG, Hales AM, McAvoy JW. TGF-beta receptor expression in lens: implications for differentiation and cataractogenesis. Exp Eye Res72:649–659, 2001.
65.
Faber SC, Robinson ML, Makarenkova HP, Lang RA. Bmp signaling is required for development of primary lens fiber cells. Development129:3727–3737, 2002.
66.
Beebe D, Garcia C, Wang X, Rajagopal R, Feldmeier M, Kim J-Y, Chytil A, Moses H, Ashery-Padan R, Rauchman M. Contributions by members of the TGFbeta superfamily to lens development. Int J Dev Biol48:845–856, 2004.
67.
de Iongh RU, Chen Y, Kokkinos MI, McAvoy JW. BMP and activin receptor expression in lens development. Mol Vis10:566–576, 2004.
68.
Liu J, Wilson S, Reh T. BMP receptor Ib is required for axon guidance and cell survival in the developing retina. Dev Biol256:34–48, 2003.
69.
Belecky-Adams TL, Adler R, Beebe DC. Bone morphogenetic protein signaling and the initiation of lens fiber cell differentiation. Development129:3795–3802, 2002.
70.
Belecky-Adams T, Adler R. Developmental expression patterns of bone morphogenetic proteins, receptors, and binding proteins in the chick retina. J Comp Neurol430:562–572, 2001.
71.
Mathura JR, Jr, Jafari N, Chang JT, Hackett SF, Wahlin KJ, Della NG, Okamoto N, Zack DJ, Campochiaro PA. Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium. Invest Ophthalmol Vis Sci41:592–600, 2000.
72.
Murali D, Yoshikawa S, Corrigan RR, Plas DJ, Crair MC, Oliver G, Lyons KM, Mishina Y, Furuta Y. Distinct developmental programs require different levels of Bmp signaling during mouse retinal development. Development132:913–923, 2005.
73.
Sakuta H, Suzuki R, Takahashi H, Kato A, Shintani T, Iemura S, Yamamoto TS, Ueno N, Noda M. Ventroptin: a BMP-4 antagonist expressed in a double-gradient pattern in the retina. Science293:111–115, 2001.
74.
Trousse F, Esteve P, Bovolenta P. Bmp4 mediates apoptotic cell death in the developing chick eye. J Neurosci21:1292–1301, 2001.
75.
Franke A, Gubbe C, Beier M, Duenker N. Transforming growth factor-beta and bone morphogenetic proteins: cooperative players in chick and murine programmed retinal cell death. J Comp Neurol495:263–278, 2006.
76.
Zhao X, Das AV, Thoreson WB, James J, Wattnem TE, Rodriguez-Sierra J, Ahmad I. Adult corneal limbal epithelium: a model for studying neural potential of non-neural stem cells/progenitors. Dev Biol250:317–331, 2002.
77.
Chang B, Smith R, Peters M, Savinova O, Hawes N, Zabaleta A, Nusinowitz S, Martin J, Davisson M, Cepko C, Hogan B, John S.Haploinsuficient BMP-4 ocular phenotypes include anterior segment dysgenesis with elevated intraocular pressure. BMC Genet2:18, 2001.
78.
Wall NA, Blessing M, Wright CV, Hogan BL. Biosynthesis and in vivo localization of the decapentaplegic-Vg-related protein, DVR-6 (bone morphogenetic protein-6). J Cell Biol120:493–502, 1993.
79.
Mohan RR, Kim WJ, Chen L, Wilson SE. Bone morphogenetic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci39:2626–2636, 1998.
80.
Obata H, Kaji Y, Yamada H, Kato M, Tsuru T, Yamashita H.Expression of transforming growth factor-beta superfamily receptors in rat eyes. Acta Ophthalmol Scand77:151–156, 1999.
81.
Kim WJ, Mohan RR, Wilson SE. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest Ophthalmol Vis Sci40:1364–1372, 1999.
82.
You L, Kruse FE, Pohl J, Volcker HE. Bone morphogenetic proteins and growth and differentiation factors in the human cornea. Invest Ophthalmol Vis Sci40:296–311, 1999.
83.
You L, Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci43:72–81, 2002.
84.
Saika S, Ikeda K, Yamanaka O, Flanders KC, Nakajima Y, Miyamoto T, Ohnishi Y, Kao WW, Muragaki Y, Ooshima A. Therapeutic effects of adenoviral gene transfer of bone morphogenetic protein-7 on a corneal alkali injury model in mice. Lab Invest85:474–486, 2005.
85.
Toyran S, Lin AY, Edward DP. Expression of growth differentiation factor-5 and bone morphogenetic protein-7 in intraocular osseous metaplasia. Br J Ophthalmol89:885–890, 2005.
86.
Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF.Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis8:241–250, 2002.
87.
Wordinger RJ, Fleenor D, Hellberg P, Pang I-H, Tovar T, Zode G, Fuller J, Clark AF. Opposing effects of TGF-β2, BMP-4 and Drm/gremlin on fibronectin production in the human trabecular meshwork: role for Drm/gremlin in glaucoma. Invest Ophthalmol Vis Sci48:1191–1200, 2007.
88.
Heijl A, Leske M, Bengtsson B, Hyman L, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Acta Ophthalmol120:1268–1279, 2002.
89.
Rohen J. Why is intraocular pressure elevated in chronic simple glaucoma. Ophthalmology90:758–765, 1983.
90.
Lutjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFβ2 for the pathogenesis of the disease. Exp Eye Res81:1–4, 2005.
91.
Fleenor D, Shepard A, Hellberg P, Jacobson N, Pang I-H, Clark AF. TGFβ2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci47:226–234, 2005.
92.
Fuchshofer R, Yu A, Welge-Lussen U, Tamm E. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-β2 in human trabecular meshwork cells. Invest Ophthamol Vis Sci48:715–726, 2007.
93.
Yu J, He S, Friedman JS, Akimoto M, Ghosh D, Mears AJ, Hicks D, Swaroop A. Altered expression of genes of the Bmp/Smad and Wnt/calcium signaling pathways in the cone-only Nrl-/- mouse retina, revealed by gene profiling using custom cDNA microarrays. J Biol Chem279:42211–42220, 2004.
94.
Shen W, Finnegan S, Lein P, Sullivan S, Slaughter M, Higgins D. Bone morphogenetic proteins regulate ionotropic glutamate receptors in human retina. Eur J Neurosci20:2031–2037, 2004.
95.
Vogt R, Unda R, Yeh L, Vidro E, Lee J, Tsin A. Bone morphogenetic protein-4 enhances endothelial growth factor secretion by human retinal pigment epithelial cells. J Cell Biochem98:1196–1202, 2006.
96.
Kane R, Stevenson L, Godson C, Stitt A, O’Brien C. Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose. Br JOphthalmol89:1638–1642, 2005.
97.
Andreev K, Zenkel M, Kruse F, Junemann A, Schlotzer-Schrehardt U.Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring. Exp Eye Res83:1162–1170, 2006.
